JCIA
GILD icon

Jackson Creek Investment Advisors’s Gilead Sciences GILD Stock Holding History

Jackson Creek Investment Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-11,547
Closed -$958K – 335
2023
Q1 		$958K Buy
11,547
+4,806
+71% +$398K 0.4% 68
2022
Q4 		$579K Buy
+6,741
New +$534K 0.26% 206
2021
Q2 		– Sell
-3,179
Closed -$205K – 321
2021
Q1 		$205K Buy
+3,179
New +$205K 0.07% 318

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jackson Creek Investment Advisors's GILD Position: Q2 2023 in Review

Jackson Creek Investment Advisors sold out of Gilead Sciences (GILD) in Q2 2023, closing a stake of 11,547 shares — an estimated $958K sold.

Jackson Creek Investment Advisors first reported a position in GILD in Q1 2021 and held it in 3 quarters. The position peaked at $958K in Q1 2023. 1,702 funds tracked by Wall St. Rank hold GILD as of Q2 2023.

  • Jackson Creek Investment Advisors reported no remaining Gilead Sciences position as of Q2 2023 after selling out during the quarter.
  • Jackson Creek Investment Advisors sold 11,547 Gilead Sciences shares in Q2 2023, an estimated $958K.
  • Jackson Creek Investment Advisors first reported a position in Gilead Sciences in Q1 2021 and held it in 3 quarters.
  • Jackson Creek Investment Advisors's Gilead Sciences position peaked at $958K in Q1 2023.
  • 1,702 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2023.

Based on Jackson Creek Investment Advisors's 13F filing for Q2 2023, filed 3 Aug 2023.